首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2211篇
  免费   88篇
  国内免费   30篇
耳鼻咽喉   3篇
儿科学   95篇
妇产科学   20篇
基础医学   425篇
口腔科学   77篇
临床医学   250篇
内科学   509篇
皮肤病学   113篇
神经病学   40篇
特种医学   271篇
外科学   194篇
综合类   48篇
预防医学   75篇
眼科学   25篇
药学   142篇
中国医学   1篇
肿瘤学   41篇
  2015年   24篇
  2013年   75篇
  2012年   22篇
  2010年   43篇
  2009年   31篇
  2008年   22篇
  2007年   48篇
  2006年   49篇
  2005年   26篇
  2003年   27篇
  2002年   20篇
  2001年   34篇
  2000年   24篇
  1999年   34篇
  1998年   83篇
  1997年   95篇
  1996年   105篇
  1995年   70篇
  1994年   73篇
  1993年   76篇
  1992年   42篇
  1991年   38篇
  1990年   41篇
  1989年   66篇
  1988年   57篇
  1987年   48篇
  1986年   51篇
  1985年   39篇
  1984年   55篇
  1983年   27篇
  1982年   31篇
  1981年   37篇
  1980年   49篇
  1979年   23篇
  1978年   27篇
  1977年   35篇
  1976年   39篇
  1975年   38篇
  1972年   24篇
  1971年   21篇
  1970年   27篇
  1969年   21篇
  1968年   20篇
  1965年   51篇
  1964年   50篇
  1963年   47篇
  1962年   41篇
  1961年   40篇
  1960年   65篇
  1959年   20篇
排序方式: 共有2329条查询结果,搜索用时 15 毫秒
111.
112.
113.
114.
115.
头皮糠疹是常见病是多发病,临床表现为头皮红斑和脱屑,提示皮损部位表皮结构和功能异常,头皮角质层代谢紊乱,最近对头皮糠疹病因和病理的研究证实马拉色菌,皮脂分泌和个体敏感性是形成上述皮损的3个关键因素,硫氧吡啶锌(PTZ或ZPT)可以有效地杀灭马拉色菌,PTZ的颗粒大小和形状对其在头皮的生物利用度有明显的影响。此外,PTZ的抗菌效果有赖于其分子结构的完整性,在外用制剂中加入附加的游离锌,可以有效防止PTZ解离,从而提高其疗效。  相似文献   
116.
AimsThe aim of the literature review was to identify new and emerging out of hospital emergency care roles and to describe their activity and impact.BackgroundDemographic changes, increased demands for health services, altered working practices, and health system economic pressures have led to the development of a disparate set of new health care roles.Data sourcesMEDLINE, EMBASE and CINAHL databases, and the two search engines Google and Google Scholar were searched for contemporary studies in the identified study area.Review methodsAll publications identified through the search were assessed for relevance. Those that discussed new roles were included (n = 34) and empirical studies (n = 14) analysed in detail.ResultsEmergency care and paramedic practitioner roles (ECP & PP) are having an impact on patient care, including an average 25% reduction in the conveyance rate to hospital, improved inter-professional working, immediacy of treatment and referral, and high patient satisfaction. Limited economic data suggests savings of between £31 (USD 55) and £37 (USD 65) per case when ECPs replace standard ambulance responders. Concerns have been expressed about patient safety, recruitment and training levels, regulatory and role implementation issues.ConclusionFurther work is required to fully understand the patient safety, clinical practice, professional role and financial implications of these new roles.  相似文献   
117.
118.
The objective of this study was to determine whether the proposed Malan radiological sinusitis typing (RST) system facilitated a level of agreement and ease of use comparable with the Lund–Mackay (LM) system for chronic rhinosinusitis. Ten observers (one otolaryngologist and nine radiologists), in two separate centres (regional and tertiary), blinded to all clinical data, used these two systems to independently and randomly score and type 15 sets of scans, recording the time to score each film. Using unweighted kappa scores, both methods facilitated a moderate level of agreement, slightly better with the LM system. The Malan system is more time efficient. Preliminarily, this study shows that the Malan RST system is easy to apply with a comparable level of agreement. The Malan RST system is a focused attempt at classifying disease extent radiologically and correlating it to a surgical approach. It emphasizes that scoring systems are vulnerable and proves to be superior to the LM system as a surgical planning tool. To score sinus disease, a Quality‐of‐Life questionnaire in association with this typing method is more appropriate.  相似文献   
119.
亚临床甲状腺功能亢进和甲状腺功能减退属于试验诊断。2002年美国甲状腺协会、美国临床内分泌医师协会和内分泌腺协会的委员组成的一个专家小组,明确了亚临床甲状腺疾病的概念,回顾了涉及风险和治疗益处的文献,并且建议进行评估和人口筛查。  相似文献   
120.
Topotecan (1.5 mg/m(2)/day for 5 consecutive days of a 21-day cycle) is an established recurrent ovarian cancer treatment, but myelosuppression can be dose limiting. This study evaluates the activity and tolerability of low-dose topotecan in our clinical experience. Case records were reviewed for patients with recurrent ovarian cancer in first through third relapse. Eligible patients had received > or =2 cycles of < or =1.25 mg/m(2) topotecan. Adverse events were evaluated using laboratory and clinical evaluation data. Twenty-seven eligible patients, most with advanced disease, received a total of 209 cycles (median, six cycles). Grade 3 or 4 hematologic toxicities during 184 cycles in 24 assessed patients were neutropenia, leukopenia, thrombocytopenia, and anemia in 35%, 28%, 36%, and 11% of cycles, and 21, 19, 16, and 10 patients, respectively. Only four grade 4 toxicities occurred: anemia (one) and thrombocytopenia (three). Myelosuppression was reversible, noncumulative, and manageable. Moreover, nonhematologic toxicity was generally mild to moderate, and the only two grade 3 events were constipation and deep vein thrombosis. Low-dose topotecan was active in this setting. Lower-dose topotecan is generally well tolerated and active in patients with pretreated ovarian cancer. Prospective clinical trials of low-dose topotecan in recurrent ovarian cancer are warranted.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号